Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02302612 · ClinicalTrials.gov registry record · NA
The CREATE Wellness Study
A NA study of Hypertension and Diabetes, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 647
- Enrollment target
- 1
- Study location
NCT02302612: Completed NA study of Hypertension and Diabetes, sponsored by Kaiser Permanente.
NCT02302612 is a NA study of Hypertension and Diabetes that has completed, run by Kaiser Permanente. The registered enrollment target is 647 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02302612, a NA study of Hypertension and Diabetes, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 647 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular disease (CVD) is the leading cause of death in the U.S. Efforts to improve CVD risk factors often fall short in complex patients with multiple co-morbid conditions, a growing, expensive, and high-risk segment of the U.S. population. The investigators are testing a multi-component behavioral intervention designed to help complex patients with CVD and other concurrent chronic conditions to become more effective agents of their own care.
Primary Outcome
We will compare the proportion of patients in the two study arms who achieve all three clinical goals of the PHASE disease management program (blood pressure control, HbA1c control (if applicable), and statin prescription) 12 months after enrollment. Risk factor control is defined according to the PHASE disease management program protocol.
Conditions Studied
Interventions
- BEHAVIORAL CREATE Wellness
- OTHER Usual Care Control
Study Locations (1)
California
- Kaiser Permanente San Jose Sabrina Wood, BA (510) 891-3551 Sabrina.B.Wood@kp.org - San Jose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 647 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
What the finished NCT02302612 record still lists
NCT02302612 is an interventional study that assigns participants to a tested intervention. The registered 647 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (82% lower).
The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which CREATE Wellness is the first listed.
NCT02302612 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02302612 about?
NCT02302612 is a clinical study titled "The CREATE Wellness Study". Cardiovascular disease (CVD) is the leading cause of death in the U.S. Efforts to improve CVD risk factors often fall short in complex patients with multiple co-morbid conditions, a growing, expensive, and high-risk segment of the U.S. population. The investigators are testing a multi-component beha...
What is the current status of trial NCT02302612?
This trial is currently completed. It is a NA study. The enrollment target is 647 participants. The study started on 2015-01. Estimated completion is 2018-09-30.
What conditions does trial NCT02302612 study?
This clinical trial studies the following conditions: Hypertension, Diabetes, Dyslipidemia, Heart Disease.
What interventions are being tested in trial NCT02302612?
The interventions under investigation include: CREATE Wellness (BEHAVIORAL), Usual Care Control (OTHER).
Who is sponsoring clinical trial NCT02302612?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02302612 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02302612's enrollment target sits among peer trials
647 97th of 470 higher than 373 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07027306 · 648 participants
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
- NCT07164456 · 648 participants · NA
Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
- NCT04863222 · 646 participants · Phase 4
Clinical and Radiographic Success of MTA vs Biodentine
- NCT07012395 · 645 participants · Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia